A randomized controlled trial of late co
โ
Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 307 KB
๐ 1 views
Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin